国: ニュージーランド
言語: 英語
ソース: Medsafe (Medicines Safety Authority)
Calcitriol 1 µg/mL
Roche Products (NZ) Ltd
Calcitriol 1 µg/mL
1 mcg/mL
Oral solution
Active: Calcitriol 1 µg/mL Excipient: Butylated hydroxyanisole Butylated hydroxytoluene Medium-chain triglycerides
Bottle, with glass pipette, 10 mL
Prescription
Prescription
Corden Pharma Colorado Inc
· Established postmenopausal osteoporosis. · Renal osteodystrophy in patients with chronic renal failure, particularly those undergoing haemodialysis. · Secondary hyperparathyroidism in patients with moderate to severe chronic renal failure (pre-dialysis). · Postsurgical hypoparathyroidism. · Idiopathic hypoparathyroidism. · Pseudohypoparathyroidism. · Vitamin D-dependent rickets. · Hypophosphataemic vitamin D-resistant rickets. · Prevention of corticosteroid induced osteoporosis.
Package - Contents - Shelf Life: Bottle, with glass pipette - 10 mL - 36 months from date of manufacture stored at or below 30°C protect from light
1988-05-25